ライフサイエンスコーパス: efflux transporter

1 s MdtD, is now designated IceT (iron citrate efflux transporter).

2 from the brain and spinal cord by the Abcg2 efflux transporter.

3 auxin maxima via the PINFORMED1 (PIN1) auxin efflux transporter.

4 in this region, is a hitherto unknown urate efflux transporter.

5 w to accurately measure the function of this efflux transporter.

6 indicating dependence on an apically located efflux transporter.

7 d-encoded membrane protein QacA, a multidrug efflux transporter.

8 es are consistent with a role for ALF5 as an efflux transporter.

9 en the gene family designation SET for sugar efflux transporter.

10 s transport substrates by the P-glycoprotein efflux transporter.

11 s interaction with the P-glycoprotein (P-gp) efflux transporter.

12 in the ABCC6 gene encoding ABCC6, a hepatic efflux transporter.

13 was recently revealed to function as a zinc efflux transporter.

14 they were not substrates for the ABCB1 drug efflux transporter.

15 opsis thaliana, AtDTX50, functions as an ABA efflux transporter.

16 for nectar production and can function as an efflux transporter.

17 range even for cell lines expressing the Pgp efflux transporter.

18 of sinusoidal uptake versus that of biliary efflux transporters.

19 ounding member of a family of bacterial drug efflux transporters.

20 , we identified a subfamily of SWEET sucrose efflux transporters.

21 and breast cancer resistance protein (ABCG2) efflux transporters.

22 udy investigates the status of the multidrug efflux transporters.

23 lence factors and multidrug resistance (MDR) efflux transporters.

24 ch copper is passed from ATOX1 to the copper efflux transporters.

25 -linking studies of bacterial and eukaryotic efflux transporters.

26 beta-catenin can influence the expression of efflux transporters.

27 ic phase I and II enzymes as well as hepatic efflux transporters.

28 ture of any MFPs associated with heavy-metal efflux transporters.

29 wo homologues of the SMR family of multidrug efflux transporters.

30 by decreasing the expression of cholesterol efflux transporters.

31 presence and absence of known inhibitors of efflux transporters.

32 s have been shown to be capable of bypassing efflux transporters.

33 e of compounds that are substrates for these efflux transporters.

34 ed here are likely employed by the multidrug efflux transporters.

35 essing large arsenals of predicted multidrug efflux transporters.

36 n of several cytochromes P450 (CYP) and drug efflux transporters.

37 E) family, which has homology with bacterial efflux transporters.

38 ce of cytochrome P450 enzymes and particular efflux transporters.

39 mediated by the ABCB1, ABCC1, and ABCG2 drug-efflux transporters.

40 nd MRP1, which are established cellular drug efflux transporters.

41 te major xenobiotic-metabolizing enzymes and efflux transporters.

42 generated by the PIN-formed family of auxin-efflux transporters.

43 iated by the ATP-binding cassette (ABC) drug efflux transporters.

44 oxidative stress and to eliminate silver via efflux transporters.

45 chieved through a system of auxin influx and efflux transporters.

46 Multidrug efflux transporters--a common and powerful resistance me

47 ced the surface abundance of the cholesterol efflux transporter ABCA1, which in turn promoted lipid a

48 Sex-based changes in cholesterol efflux transporters Abca1 and Abcg1 were also observed a

49 fflux; notably, they overexpress cholesterol efflux transporters ABCA1 and ABCG1.

50 e promoter of the major cellular cholesterol efflux transporter, ABCA1, in LNCaP prostate cancer cell

51 ected the function of membrane-embedded drug efflux transporter ABCB1, triggering the integrated stre

52 duced inhibition of the multidrug-resistance efflux transporter ABCB1, which is frequently expressed

53 cancer stem cells expressing the multi-drug efflux transporter ABCB1.

54 Three ABC efflux transporters (ABCB1, ABCC3, and ABCB5) showed sig

55 ke increase in the activity of the multidrug efflux transporter ABCB1a.

56 The drug efflux transporter ABCB5 identifies cancer stem-like cel

57 te that genetic variation within an ABC-drug efflux transporter (Abcb5) affected susceptibility to HI

58 The ubiquitous efflux transporter ABCC5 (ATP-binding cassette subfamily

59 ABCC6 encodes the putative efflux transporter ABCC6, which is predominantly express

60 ations in the ABCC6 gene encoding a putative efflux transporter ABCC6.

61 The gene at default, ABCC6, encodes an efflux transporter, ABCC6, which is a critical player re

62 in the ABCC6 gene, which encodes a putative efflux transporter, ABCC6.

63 ations in the ABCC6 gene encoding a putative efflux transporter, ABCC6.

64 polymorphic variant of the chemotherapy drug efflux transporter ABCG2, which contributes to normal ti

65 , metabolic (G6PD, TKT, PPARgamma), and drug efflux transporter (ABCG2, MRP3, MRP4) genes.

66 An efflux transporter, ABCG2, was lower, while mRNAs encodi

67 he yeast (Saccharomyces cerevisiae) arsenite efflux transporter ACR3 into Arabidopsis to evaluate how

68 imals, constitutively produces the multidrug efflux transporter AcrB (AcrB(HI)).

69 is toxic only in cells lacking the multidrug efflux transporter AcrEF.

70 ycoprotein (P-gp) was identified as the main efflux transporter across the BBB, in vivo and in vitro.

71 ssion of nutrient transporters and polarized efflux transporter activity.

72 4 receptor, PI3K/AKT signaling, and ABC drug efflux transporter activity.

73 cytochrome P450 mono-oxygenase system, drug efflux transporter adenosine triphosphate-binding casset

74 e P-gp knockout mouse provided evidence that efflux transporters affected the amount of Abeta lowerin

75 the most studied ATP-binding cassette (ABC) efflux transporter and contributes to chemoresistance.

76 Here, we have cloned ABCB5, a rhodamine efflux transporter and novel member of the human P-glyco

77 lasma membrane and functions as a nucleotide efflux transporter and thus plays a role in the regulati

78 of the Small Multidrug Resistance family of efflux transporters and actively expels positively charg

79 ytokinins mediated by the PIN class of auxin efflux transporters and AHP6, an inhibitor of cytokinin

80 hanisms include the regulation of uptake and efflux transporters and buffering of the free metal conc

81 of the anticancer drug vinorelbine with drug efflux transporters and cytochrome P450 3A drug-metaboli

82 le mice because of expression differences in efflux transporters and cytochromes in the liver, ileum

83 cerevisiae strain lacking sodium ion (Na(+)) efflux transporters and increased salt tolerance of wild

84 RACURVATA 2 or FKBP42, associates with auxin efflux transporters and is essential for their biologica

85 Our discussion includes efflux transporters and the molecular timing mechanisms

86 ecent reports on the structures of multidrug efflux transporters and their cognate regulators have su

87 asma bound, are substrates for an intestinal efflux transporter, and have low biliary excretion.

88 C30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations b

89 PIN-FORMED (PIN) proteins are proposed auxin efflux transporters, and auxin fluxes can seemingly be p

90 ellular drug concentrations mediated by drug efflux transporters, and permeability barriers associate

91 ced effect on mitochondrial metabolism, drug-efflux transporters, and stress-response activation.

92 ROPIC DRUG RESISTANCE TRANSPORTER9, an auxin efflux transporter; and two APETALA2/ETHYLENE RESPONSE F

93 expression alters the trafficking of 2 auxin efflux transporters-Arabidopsis PM-located auxin efflux

94 Sugar efflux transporters are essential for the maintenance of

95 lood-brain barrier (BBB); one or both of the efflux transporters are inhibitable by probenecid.

96 nce and encodes the Al-activated root malate efflux transporter associated with tolerance.

97 educe recognition by P-glycoprotein, the key efflux transporter at the blood-brain barrier.

98 and expression of the P-glycoprotein (P-gp) efflux transporter at the blood-brain interface further

99 east cancer resistance protein (ABCG2) are 2 efflux transporters at the blood-brain barrier (BBB) tha

100 le targeted therapies is severely limited by efflux transporters at the blood-brain barrier (BBB).

101 ants acting through AhR to target xenobiotic efflux transporters at the blood-brain barrier and thus

102 ATP-driven efflux transporters at the blood-brain barrier both prot

103 ABC (ATP Binding Cassette) efflux transporters at the blood-brain barrier, P-glycop

104 nt models of epilepsy suggest that multidrug efflux transporters at the blood-brain barrier, such as

105 oss-of-function mutations in the cholesterol efflux transporter ATP-binding cassette transporter A1 (

106 acrophage cholesterol by targeting the lipid efflux transporters ATP binding cassette (ABC)A1 and ABC

107 The copper efflux transporters ATP7A and ATP7B sequester intracellu

108 cimetidine, colchicine) and also affinity to efflux transporters (atropine and chloramphenicol) are t

109 ubstrates of the Bacillus subtilis multidrug efflux transporter Bmr, induce the expression of Bmr thr

110 in plants is regulated in part by the borate efflux transporter Bor1, a member of the solute carrier

111 interaction of erlotinib with the multidrug efflux transporters breast cancer resistance protein (hu

112 negatively regulates PIN-FORMED (PIN) auxin efflux transporters by affecting their plasma membrane l

113 SLC30A10, a cell-surface-localized manganese efflux transporter, cause a heritable manganese metaboli

114 that rte encodes a membrane-localized boron efflux transporter, co-orthologous to the Arabidopsis th

115 lC is a constitutively expressed, tripartite efflux transporter complex that functions as the primary

116 The chromosomally encoded Tet38 efflux transporter confers resistance to tetracycline an

117 M. sedula mutant lacking the primary copper efflux transporter, CopA, became copper sensitive.

118 SLC30A10 is a manganese efflux transporter critical for whole-body manganese exc

119 Multidrug-efflux transporters demonstrate an unusual ability to re

120 including those encoding putative multidrug efflux transporters, detoxification proteins, extracytop

121 an Arabidopsis (Arabidopsis thaliana) boron efflux transporter displayed boron deficiency phenotypes

122 hat the inhibition of ABCB and ABCC-types of efflux transporters disrupts the ordered distribution of

123 ia coli MacAB-TolC is a tripartite macrolide efflux transporter driven by hydrolysis of ATP.

124 The high level of expression of efflux transporters (e.g., P-glycoprotein (P-gp) and bre

125 Increased activity of efflux transporters, e.g., P-glycoprotein (P-gp) and bre

126 The multidrug efflux transporter EmrE from Escherichia coli requires a

127 ted by the plasma membrane localized citrate efflux transporter encoded by SbMATE.

128 gnificantly to the flux towards product, and efflux transporters ensure the accumulation of product i

129 Multidrug efflux transporters, especially those that belong to the

130 The PIN family of auxin efflux transporters exhibit polar plasma membrane (PM) l

131 th tls1 and rotten ear (rte), the proposed B efflux transporter, exhibit a dosage-dependent defect in

132 6 gene, which encodes ABCC6, a transmembrane efflux transporter expressed primarily in the liver.

133 own about the natural functions of multidrug-efflux transporters expressed by bacteria.

134 particular, neuronal activity regulates BBB efflux transporter expression and function, which is cri

135 In this study, changes in efflux transporter expression are investigated in mice c

136 In other barrier and excretory tissues, efflux transporter expression is regulated by certain li

137 aused by increased P-glycoprotein (Pgp) drug efflux transporter expression.

138 Additionally, the high ABCA5 (efflux transporter) expression in resistant cells also s

139 ly of bacterial transporters, the SET (sugar efflux transporter) family, has been recently reported.

140 generated a conditional deletion of the iron efflux transporter ferroportin (Fpn) in astrocytes, and

141 ammalian iron efflux is mediated by the iron efflux transporter ferroportin (Fpn).

142 e action of the hormone hepcidin on the iron efflux transporter ferroportin.

143 the synergistic actions of the ferrous iron efflux transporter, ferroportin (Fpn) and a multicopper

144 to the portal circulation via the sole iron efflux transporter, ferroportin.

145 ssette, subfamily B member 11 (ABCB11) is an efflux transporter for bile acids on the liver canalicul

146 TROPIC DRUG RESISTANCE9, encoding a putative efflux transporter for products from the phenylpropanoid

147 Multidrug efflux transporters, found in all living cells and prote

148 ere we utilized FrvA, a high-affinity Fe(2+) efflux transporter from Listeria monocytogenes, as an in

149 In Gram-negative bacteria, multidrug efflux transporters function in complexes with periplasm

150 tentatively identified as a truncated cation efflux transporter gene and a PbrR family regulator gene

151 egulates the expression of the bmr multidrug efflux transporter gene in response to myriad lipophilic

152 SNPs within the efflux transporter genes ABCC1 (ATP-binding cassette, su

153 Four sugar efflux transporter genes were modified in rice at high e

154 rchin eggs and embryos express low levels of efflux transporter genes with homology to the multidrug

155 s overexpress CDR1 and CDR2, two fluconazole efflux transporter genes, and a cdr1 mutation decreases

156 stimulated the expression of Si channel and efflux transporter genes- Lsi1 and Lsi2 while the additi

157 f the Neisseria gonorrhoeae mtrCDE multidrug efflux transporter genes.

158 Although the role of PIN auxin efflux transporters has been clearly assigned during emb

159 biological importance, the identity of sugar efflux transporters has remained elusive.

160 Although putative auxin-influx and -efflux transporters have been identified by using molecu

161 Ferroportin (FPN) is the sole iron efflux transporter identified to date in animals, and th

162 ABCG2 is recognized as an important efflux transporter in clinical pharmacology and is poten

163 ABCB1) provided evidence of the role of this efflux transporter in effectively restricting the brain

164 results provide evidence of ABCA3 as an MLF efflux transporter in human macrophages and support its

165 Permeability-glycoprotein (P-gp), an efflux transporter in several organs, acts at the blood-

166 SLC30A10, a cell surface-localized manganese efflux transporter in the brain and liver, induce famili

167 strate activities of the cyclic prodrugs for efflux transporters in Caco-2 cells and in the intestina

168 k exhibited very poor substrate activity for efflux transporters in Caco-2 cells.

169 all exhibited strong substrate activity for efflux transporters in Caco-2 cells.

170 The recent discovery of putative iron efflux transporters in Salmonella enterica serovar Typhi

171 r studies define a system of zinc influx and efflux transporters in the vacuole that play important r

172 arose from its strong substrate activity for efflux transporters in these biological barriers.

173 ast cancer resistance protein (ABCG2, an MTX efflux transporter) in TEL-AML1 ALL, and lower expressio

174 ulated expression of SLC30A10, a critical Mn efflux transporter, in the liver and intestines.

175 rug resistance protein 4 (MRP4), a cAMP/cGMP efflux transporter, in the regulation of fluid secretion

176 Our study, using specific inhibitors of efflux transporters, indicates that the major activity i

177 and was negated by cotreatment with the drug efflux transporter inhibitor elacridar.

178 forming P-gp or an ABC drug exporter from an efflux transporter into a drug uptake pump would constit

179 P-glycoprotein (P-gp) is an efflux transporter involved in limiting the oral bioavai

180 tes CueR, eliciting the translation of Cu(+) efflux transporters involved in metal tolerance.

181 tochemicals and is also one of the prominent efflux transporters involved in multidrug resistance (MD

182 The permeability-glycoprotein (P-gp) efflux transporter is densely expressed at the blood-bra

183 that the model of dual acid influx and acid efflux transporters is sufficient to account for pHi reg

184 ely studied family of PIN-formed (PIN) auxin efflux transporters is unclear, and studies using hetero

185 ding cassette (ABC) membrane-associated drug efflux transporter, is known to localize at the blood-br

186 ding cassette transporter P-glycoprotein, an efflux transporter known to detoxify taxol, were found t

187 Multidrug resistance protein 4 (Mrp4) is an efflux transporter known to transport several xenobiotic

188 rcome the BBB, both passive permeability and efflux transporter liability of a compound must be addre

189 TSSC5 encodes an efflux transporter-like protein with 10 transmembrane do

190 d advances in structure determination of ABC efflux transporters, little is known regarding the locat

191 Mammalian P-glycoproteins are active drug efflux transporters located in the plasma membrane.

192 both the lsi2 mutant lacking the Si/arsenite efflux transporter Lsi2 and its wild-type cultivar, with

193 We show how auxin response genes and auxin efflux transporters may be affected by the presence of c

194 -3, and KB-3 cell lines that overexpress the efflux transporters MDR1 (KBV-1) and BCRP (KBH5.0).

195 otein genes (MRP1/MRP2, which encode for the efflux transporter Mrp1/Mrp2) and the multidrug resistan

196 ters Oatp1a/1b (Slco1a/1b(-/-)/(-/-)) or the efflux transporter Mrp2 (Abcc2(-/-)) were intravenously

197 ical multidrug-resistance-associated protein efflux-transporters (MRPs) in the renal proximal tubule

198 affect transport activity of two other major efflux transporters, multidrug resistance protein 2 and

199 Staphylococcus aureus utilizes efflux transporter NorA to pump out a wide range of stru

200 P-glycoprotein-ATPase is an efflux transporter of broad specificity that counteracts

201 AcrD is an efflux transporter of E. coli that provides resistance t

202 The AcrB trimeric multidrug efflux transporter of Escherichia coli pumps out a very

203 ted protein 2 (MRP2/ABCC2) is a polyspecific efflux transporter of organic anions expressed in hepato

204 g cassette subfamily G member 2 (ABCG2), the efflux transporter of protoporphyrin IX.

205 46% similarity with the plasmid-encoded TetK efflux transporter of S. aureus.

206 Overexpression of NorA, an endogenous efflux transporter of Staphylococcus aureus, confers res

207 lycoprotein functions as a broad specificity efflux transporter of structurally diverse natural produ

208 Our findings demonstrate that the efflux transporter of the siderophore SA contributes to

209 ted in the terminal ileum and colon, as were efflux transporters of breast cancer resistance protein

210 Efflux transporters of the adenosine triphosphate-bindin

211 Multidrug efflux transporters of the ATP-Binding cassette (ABC) fa

212 should consider the adverse impact of active efflux transporters on efficacy.

213 t of varying the concentrations of the auxin efflux transporters on the sizes of the different root r

214 temness signaling pathways, surface markers, efflux transporters, or components of complex tumor micr

215 , various conjugating enzymes, ATP-dependent efflux transporters, oxidative detoxification proteins,

216 at selectively kill cells overexpressing the efflux transporter P-glycoprotein (MDR1, P-gp, ABCB1).

217 ted concurrent inhibition of intestinal drug efflux transporter P-glycoprotein (P-gp) and drug metabo

218 increases the expression and activity of the efflux transporter P-glycoprotein (P-gp) encoded by ABCB

219 Abeta across the blood-brain barrier is the efflux transporter P-glycoprotein (P-gp) in the luminal

220 coverage) occurring throughout the multidrug efflux transporter P-glycoprotein (P-gp) in three distin

221 The drug efflux transporter P-glycoprotein (P-gp) is highly expre

222 nner that could occur with inhibition of the efflux transporter P-glycoprotein (P-gp).

223 oupled conformational cycle of the mouse ABC efflux transporter P-glycoprotein (Pgp; also known as AB

224 that substrates and inhibitors have with the efflux transporter P-glycoprotein has been the subject o

225 resistance gene (MDR1, which encodes for the efflux transporter P-glycoprotein).

226 However, the specific effect of VEGF on the efflux transporter P-glycoprotein, a critical component

227 Finally, we show that the efflux transporter P-glycoprotein, which was previously

228 n of the Abcb1b gene, which encodes the drug efflux transporter P-glycoprotein.

229 ing enzymes, shares many substrates with the efflux transporter P-gp.

230 er dysfunction is overexpression of the drug efflux transporters P-glycoprotein (P-gp) and breast can

231 nd high membrane permeability, and is not an efflux transporter (P-gp) substrate.

232 ssion and transport activity of the key drug efflux transporter, P-glycoprotein (6 h EC(50) was appro

233 aline phosphatase (ALP), and presence of the efflux transporter, P-glycoprotein (P-gp, ABCB1).

234 The multispecific efflux transporter, P-glycoprotein, plays an important r

235 phic analyses in knockout mice showed that 2 efflux transporters-permeability glycoprotein (P-gp) and

236 mediated primarily by mutations in the drug efflux transporter PfCRT, we have explored whether PfCRT

237 ux transporters-Arabidopsis PM-located auxin efflux transporter PIN-formed 1 (PIN1) and Arabidopsis P

238 ed 1 (PIN1) and Arabidopsis PM-located auxin efflux transporter PIN-formed 3 (PIN3)-to the PM, thereb

239 d NPC4 were shown to interact with the auxin efflux transporter PIN-FORMED2 (PIN2).

240 Finally, both Arabidopsis thaliana auxin efflux transporter pin1 and influx transporter lax2 muta

241 recycling, and PM accumulation of the auxin efflux transporter PIN2 in Arabidopsis thaliana.

242 re in patients is associated with uptake and efflux transporter polymorphisms.

243 -family C member 6 (ABCC6), an ATP-dependent efflux transporter present mainly in the liver.

244 ABCC6 is an efflux transporter primarily expressed in liver facilita

245 inhibition while maintaining a favorable CNS efflux transporter profile.

246 with improved physicochemical properties and efflux transporter profiles while maintaining excellent

247 and property-based drug design and expanded efflux transporter profiling to identify structurally di

248 Multidrug efflux transporters protect cells in the brain from pote

249 apolipoprotein E, and the major cholesterol-efflux transporter protein ATP-binding cassette transpor

250 a hypothetical, saturable renal basolateral efflux transporter provided the first unified explanatio

251 th reduced expression of a tonoplast sucrose efflux transporter, PtaSUT4, exhibit reduced shoot growt

252 As a substrate of the P-glycoprotein (P-gp) efflux transporter, quinacrine is actively exported from

253 Changes in the expression of drug influx and efflux transporters, rather than activation of cell grow

254 ated levels of drug-metabolizing enzymes and efflux transporters, resulting from CAR activation in va

255 lls stably expressing specific uptake and/or efflux transporters revealed that OATP1B1, OATP1B3, and

256 ndings argue that the inhibition of the P-gp efflux transporter should improve the poor pharmacokinet

257 enger receptors showed lower and cholesterol efflux transporters showed higher expression in CXCL4- t

258 , rare loss-of-function variants in the zinc efflux transporter SLC30A8 reduce T2D risk.

259 data suggesting their therapeutic is a drug efflux transporter substrate?

260 be important when therapeutically targeting efflux transporter substrates to the CNS.

261 sistance must be nonspecific, involving drug-efflux transporters such as ATP-binding cassette sub-fam

262 lin-resistant S. aureus strains that express efflux transporters such as NorC in hospital and communi

263 ate biological targets, including intestinal efflux transporters such as P-glycoprotein (P-gp).

264 lthough doxorubicin is a known substrate for efflux transporters such as P-glycoprotein (P-gp; MDR1,

265 tumor homing capabilities, MSCs overexpress efflux transporters such as P-glycoprotein and are highl

266 l lines, both of which do not express common efflux transporters such as P-glycoprotein at the plasma

267 s that are often protected from treatment by efflux transporters, such as P-glycoprotein (P-gp) at th

268 named Xa13 or OsSWEET11, a member of sucrose efflux transporter SWEET gene family).

269 We provide evidence that the efflux transporters TAT1, LAT3 and LAT4 are present in t

270 stance-associated protein 1 (MRP1) is a drug efflux transporter that has been implicated in the patho

271 ABCB1 (P-glycoprotein/MDR1) is a multidrug efflux transporter that has previously been involved in

272 The MDR1 gene encodes P-glycoprotein 170, an efflux transporter that is highly expressed in intestina

273 ly downregulated the expression of BCRP1, an efflux transporter that is highly expressed in the CNS v

274 gp), an endogenous blood-brain barrier (BBB) efflux transporter that is involved in brain-to-blood tr

275 ancer resistance protein (BCRP, ABCG2) is an efflux transporter that plays a crucial role in multidru

276 is a proton motive force-dependent multidrug efflux transporter that recognizes multiple toxic chemic

277 Escherichia coli AcrB is a multidrug efflux transporter that recognizes multiple toxic chemic

278 Escherichia coli AcrB is a multidrug efflux transporter that recognizes multiple toxic chemic

279 that SLC30A10 is a cell surface-localized Mn efflux transporter that reduces cellular Mn levels and p

280 auxin within tissues are regulated by auxin efflux transporters that are polarly localized in cells.

281 ukaryotes use a highly conserved set of drug efflux transporters that confer pleiotropic drug resista

282 s/regulators, soluble chaperones, and influx/efflux transporters that control the Cu(+) levels in P.

283 r of the ATP binding cassette superfamily of efflux transporters that mediates the apical efflux of o

284 Although Pgp is generally thought to be an efflux transporter, the mechanism of action remains elus

285 ith the lack of expression of organic cation efflux transporters, there was little efflux of IDT307 i

286 n, composition and assembly of the triclosan efflux transporter TriABC-OpmH from Pseudomonas aerugino

287 of the wheat (Triticum aestivum) root malate efflux transporter underlying Al resistance, TaALMT1.

288 that the barriers are tightened selectively (efflux transporter upregulation) by oxidative stress, pr

289 In addition, Slc30a10, encoding a manganese efflux transporter, was one of the genes most induced by

290 rugs and thus their substrate activities for efflux transporters, we synthesized cyclic prodrugs of t

291 pression, and localization of the PIN1 auxin efflux transporter, were intact in bps1 mutants, suggest

292 bacterial heterodimeric ATP-binding cassette efflux transporter, were used to demonstrate the protein

293 erties of the cellular membrane augmented by efflux transporters, which preclude intracellular penetr

294 owth and differentiation, and the ABCG2 drug efflux transporter will be presented.

295 review, we summarize the RND superfamily of efflux transporters with a primary focus on the assembly

296 s, restrictive barrier formation, influx and efflux transporters with relevance to understanding peri

297 ticular, impairment of the astrocyte lactate efflux transporter, with resultant decrease of spinal co

298 Little is known about iron efflux transporters within bacterial systems.

299 pressing a native expressed endogenous auxin efflux transporter (ZmPIN1a) fused to yellow fluorescent

300 SLC30A1 encodes the ubiquitous zinc efflux transporter ZnT1 (zinc transporter 1).